Keywords
Environmental enrichment, cage, cancer, tumor, mice
This article is included in the Preclinical Reproducibility and Robustness gateway.
Environmental enrichment, cage, cancer, tumor, mice
Environmental enrichment (EE) for mice in laboratory conditions provides enlarged cages for large groups of mice and provides objects which stimulate enhanced sensory, cognitive, social and physical activity compared with mice housed in standard conditions. The positive effects of EE on mice (reviewed in Nithianantharajah and Hannan1) have been reported from numerous studies (from a PubMed search on 9 May 2013 using the phrases “environmental enrichment” and “enriched environment”): at least 150 papers have been published showing enhanced neurogenesis, cognitive capacity, memory, learning, neuronal pathways, and improvements in diseases such as Alzheimer’s, Huntington’s, amyotrophic lateral sclerosis and brain injury. Approximately 100 papers have been published showing reduction in anxiety levels, social defeat, emotionality, depression, drug addiction, alopecia, and stereotypies. In addition, approximately 12 studies have investigated the effect of EE in infectious disease, immunity, atherosclerosis, lifespan, inflammation, asthma and obesity; and about 10 studies have dealt with its effects on olfaction, hearing, photoreceptors, and sight. Only three studies in mice have been performed on the effect of EE on cancer development or treatment.
Three papers have reported on tumor growth in mice housed in enriched environments compared with those housed in standard conditions2–4. Cao et al.2 reported significantly decreased growth in subcutaneous (s.c.) B16 (by 43%), B16F10 (by 77%) and MC38 (by 55%) tumors in mice housed in EE conditions. Nachat-Kappes et al.3 reported significantly smaller s.c. E0771 mammary tumors up to 10 days after tumors were inoculated orthotopically in EE housed mice, but thereafter there was no statistically significant difference in tumor size. Benaroya-Milshtein et al.4 reported no significant difference in size of untreated s.c. 38C-13 B-cell lymphoma tumors. However, all three studies have reported statistically significant differences in other parameters between EE housed mice and standard housed mice: Cao et al.2 reported markedly lower leptin levels and upregulation of brain-derived neurotrophic factor in EE mice, Nachat-Kappes et al.3 reported a statistically significant increase in caspase-3 levels in the tumors of EE housed mice, and Benaroya-Milshtein et al.4 reported reduced tumor growth and significantly greater survival of EE housed mice after immunization with an idiotype-vaccine prior to tumor injection, with 44% disease-free compared with 0% in standard cages. Thus all three studies report an influence of EE on tumors.
Our primary goal was to see if we could replicate the significant difference in tumor size found in the EE group by Cao et al.2, who injected B16F10 s.c. and found a 77% reduction in tumor mass in EE mice and that 17% of mice had no visible tumors, compared with 0% of mice in standard caging. If we could replicate these results, this finding would have important consequences for the way in which we would need to house mice to perform future experiments when testing therapies to combat cancer.
The mouse (C57BL/6) B16F10 melanoma tumor cell line5 (from NP Restifo, National Cancer Institute, Bethesda, USA) was maintained in complete medium consisting of DMEM (Gibco, Life Technologies, Grand Island, NY) with 10% heat-inactivated fetal calf serum (FCS; MultiSer, Thermo Trace, Melbourne) and additives (2 mM glutamine (Gibco), 100 μg/ml streptomycin (Sigma-Aldrich, St Louis, MO) and 100 U/ml penicillin (Sigma-Aldrich) in a humidified incubator at 37°C with 5% CO2.
The black low density polyethylene plastic EE cage (Plastime, Castegnero, Italy) measured 81 cm (length) × 57 cm (width) × 34 cm (height) internally, and had a wire cage lid (Figure 1). It was stocked with the following stimulatory equipment: 2 exercise wheels, 3 PVC plumbing elbow pipes (2.54 cm diameter) bent at 90°, a 2.54 cm plumbing T-piece, 2 standard cages with holes drilled in their sides to allow mouse access and with tissues inside and pellet food provided on their wire lids, 2 cardboard boxes of tissues cut in half and inverted (refuges) and about 20 tissues scattered around. An extra EE cage was also purchased and when mice cages were cleaned fortnightly, all equipment and mice were transferred to the new cage which had clean bedding. Mice were allowed to acclimatize to their conditions for six weeks, prior to injection with tumors. The mice were not handled except for transferring during cage cleaning, and tumor measurement (on day 13 after tumor injection).
The four standard cages used measured 28 cm (length) × 14 cm (width) × 12 cm (height) internally and were made of polycarbonate plastic (Wiretainers, Melbourne, Australia).
Fortnightly cleaning of cages was as follows: The EE cage was scraped out manually, then cage and toys were soaked for 10 mins in hot water with 2–5% Decon 90 (Decon Laboratories Ltd, East Sussex, UK) solution, scrubbed with a brush, and rinsed in hot water. The cage was left for 2 weeks before being used again, as two cages were alternated. The standard cages were scraped out manually, washed in a tunnel washer using washing machine powder, before autoclaving.
Both EE and standard cages had a layer of FibreCycle (recycled paper pellets; FibreCycle P/L, Yatala, Qld, Australia) animal bedding pellets to a depth of approximately 2 cm on the bottom of the cages, and all mice were fed with irradiated Barastoc mouse food cubes (Ridley AgriProducts, Melbourne, Australia) based on wheat, wheat byproducts, oats, meat meal, canola oil, soyabean meal, skim milk powder, molasses, salt, vitamins, and minerals. Drinking water was filtered tap water adjusted to pH 2.5–3 with hydrochloric acid.
Both EE and standard cages were housed in the same room of the animal facility. Throughout the experiment mice were maintained on a 13-hour-on : 11-hour-off lighting schedule (lights on at 6.00 am and off at 7.00 pm) in a room thermostatically maintained at 20°C. Food and water were available ad libitum. The air in the facility was not HEPA filtered or humidity controlled, and there were 15 air changes per hour.
The Specific Pathogen Free (SPF) facility houses sentinel mice in each rack and these are monitored regularly for infectious agents with the aim of detecting any pathogenic agents. The facility was monitored for the microorganisms listed in Table 1, and none of these species were detected during the period of this study. The following microbiota are detected in the mice in this facility and are considered endemic in the SPF-3 rated animal facility: Mouse Norovirus, Rotavirus, Protozoa (Chilomastix bettencourti or Entamoeba muris, which are frequently found in intestinal tracts of normal rodents), Proteus spp. (probably P. mirabilis as this is a common inhabitant of the upper respiratory tract and faeces of normal mice), and Helicobacter spp.
Ethics statement: This study was carried out in strict accordance with the recommendations of the Victorian Bureau of Animal Welfare, Department of Primary Industries, and the National Health and Medical Research Council’s Australian code of practice for the care and use of animals for scientific purposes. The protocol was approved by the Peter MacCallum Cancer Centre Animal Experimentation Ethics Committee under Permit number E396. All efforts were made to minimize suffering.
Wild type male C57BL/6 mice were purchased from the Walter and Eliza Hall Institute of Medical Research (Bundoora, Australia), at age three weeks, and randomly assigned in either the EE cage (20 mice) or in four standard cages with five mice each (20 mice in this group). Mice were habituated to their cages for 6 weeks prior to tumor injection. During the habituation period two mice died (one found dead and one was culled for hydrocephalus) in the standard housed group, so that this group consisted of 18 mice for tumor injection. After the six weeks habituation, mice were shaved on the flank and inoculated s.c. with 100 μl of a single-cell suspension of 1×105 B16F10 melanoma cells in Ca2+- and Mg2+-free phosphate-buffered saline (Merck, Darmstadt, Germany) (day 0). The same person injected all mice for consistency. Tumor growth was monitored using calipers, and tumor area was calculated as the product of two perpendicular diameters. Mice were culled when tumors reached 200 mm2 in size or at the first signs of stress.
C57BL/6 male mice at three weeks of age were divided into two groups. One group of 20 mice was placed in an enriched environment (Figure 1), which consisted of a large cage (surface area of 231 cm2 per mouse) with numerous pieces of stimulatory equipment (exercise wheels, tunnels, refuges, tissues), and the 18 mice in the other group were placed in four standard cages (4–5 mice/cage with surface area of 78 cm2 per mouse) with tissues only.
After six weeks of habituation in their respective cages, all mice were injected subcutaneously with 1 × 105 cells of B16F10 on their flank. Mice were not handled except for transfer to clean cages during routine fortnightly cleaning, until day 13 when all tumors were measured.
Figure 2 shows the tumor measurements on days 13 and 16 after tumor injection. Tumors on 33% (six of the standard group of 18 mice) and 30% (six of the EE group of 20 mice) of mice were ≥ 200 mm2 on day 13 and these mice were culled on this day. The average size of tumors was 164.3 ± 25.4 (SEM) mm2 (standard conditions) and 155.7 ± 29.8 (SEM) mm2 (EE conditions) on day 13. Average tumor size between the two groups was not statistically significant (p=0.69). On day 16, 72% of standard housed mice (13 of the 18 mice) and 65% (13 of the 20 mice) of EE housed mice had been culled as tumors of these mice had reached the 200 mm2 size threshold. All mice except one in each group had developed tumors. The experiment was terminated on day 16 as there was no significant difference between tumor sizes in the two groups.
Table 2 summarizes the conditions for previously published studies on cancer in mice housed in EE cages, compared with the current study, in an attempt to ascertain why the results between the studies were so different. Floor space area per mouse varied from 180 to 1250 cm2, with the floor space largest in the study by Cao et al.2, which was about five times that of our study. The number of mice per EE cage varied between five and 20, but was similar between the Cao et al. study and our study. Enrichment toys and equipment were similar between all studies, as was the age that the mice were introduced into the cages (3–4 weeks) and the time for habituation (6–9 weeks). Tumor lines were different between studies, as were the sites of s.c. injection and the frequency of handling the mice. Mice were male in all studies except one3 and of the C57BL/6 strain in all studies except one4. Other parameters that could have caused variability were not mentioned in all studies, such as food composition, cage material (chemical composition and emission of fumes may vary), cage cleaning (chemical residue may vary), lighting, temperature, whether standard and EE cages were housed in the same room, bedding composition, and microbiota detected in each animal facility. With so many unspecified variables it is difficult to determine what is causing three of the studies to find no durable statistically significant difference in tumor size between EE and standard housed mice, whilst one study found a significant difference.
We attempted to replicate the interesting findings by Cao et al.2, that tumors in mice housed in EE conditions grew at a significantly reduced rate, compared with mice housed in standard cages and that more EE housed mice were resistant to tumors, with 15% showing no visible tumor at day 19 (all control mice showed visible tumors).
We were not able to replicate these results, and found no statistical difference in tumor size between the two groups, even though we set up an enlarged cage with much greater floor space per mouse than in the standard cages. We also provided toys and equipment similar to Cao et al. to give an enriching and stimulating environment, housed a similarly large number of mice together so that there was more social interaction, introduced the mice at the same age into the cages (at 3 weeks) and habituated them for the same time (6 weeks) before tumor injection. The same tumor line (B16F10) was used, and we injected the same number of cells s.c., injected the same sex mice (male), and limited handling of the mice to the same day (day 13 post tumor injection except for cleaning).
There are several differences which may explain why we could not replicate these results. Firstly, there was a noticeable difference in growth kinetics between the B16F10 tumor line cells that we used and those used by Cao et al. The B16F10 tumors in our study grew faster and 30% of EE housed mice had to be culled on day 13, whereas those in the Cao et al. study were all still alive on day 17. In addition, the floor space per mouse was about five times greater in the Cao study than ours. Also, the toys and other objects were not identical in both studies. Problems of not standardizing EE design and lack of reproducibility of results between and within studies is reviewed by Fares et al.6, who have attempted to remedy this by producing a standardized EE cage (for rats).
We are not claiming that EE housing cannot impact on tumor growth, but our results show that EE housing will not consistently reduce tumor growth in all animal facilities and that there may be factors which override the benefits of EE housing. These factors appear to vary between animal facilities, as other studies3,4 have also found no durable statistical difference in tumor size between the two groups.
EE housing would thus appear to offer some benefits in certain animal facilities, but these benefits may be negated or hindered in other animal facilities by other factors. These factors could consist of, for example, differences in the microbiota of the mice. Tavakkol et al.7 examined the skin flora of mice and found 20 different species of microorganisms on the skin alone of mice in an SPF facility. There is likely to be variability in microbiota of mice in different animal facilities, and this could impact on the immune systems and limit the beneficial effect of EE housing. The impact of microbiota on the immune system, inflammation and cancer has been reviewed extensively8–11. Similarly, the food given to the mice probably varied between facilities. Diet also has an influence on microbiota12. In addition, variables such as noise and number of people accessing the facility may have a negative impact on EE mice despite their enriched conditions, which may vary between animal facilities. There were many variables with no information specified in the three published studies summarized in Table 2, which could have been different in our animal facility and counteracted any benefits of EE conditions in our study. Difficulties with designing EE studies and comparison between studies to draw definitive conclusions are reviewed by Toth et al.13, and the great variability of parameters between EE studies is reviewed in Benefiel et al.14 and Bayne15.
Our study and review of the literature has demonstrated that EE housing 20 mice in a large cage and providing toys and a stimulating environment, does not universally lead to reduced tumor growth, and that other factors appear to be acting either in concert with EE or against EE conditions to provide the variable results found.
MK conceived the study. MK and JW designed the experiments. JW, PD and MK carried out the research. JW and MK prepared the first draft of the manuscript. All authors were involved in the revision of the draft manuscript and have agreed to the final content.
MK, PD and JW funded by National Health & Medical Research Council of Australia, Grant #1006188.
We wish to thank the Peter MacCallum Cancer Centre Animal Facility staff, especially Shellee Brown, for their care and maintenance of mice used in this study.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 12 Jun 13 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)